Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumours.
about
Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivityInhibition of Poxvirus Gene Expression and Genome Replication by Bisbenzimide DerivativesIn vivo radioprotection of mouse brain endothelial cells by Hoechst 33342.Heterogeneous vascular dependence of tumor cell populationsDNA ligands as radioprotectors: molecular studies with Hoechst 33342 and Hoechst 33258.Analysis of distribution of tumor- and preneoplasia-infiltrating lymphocytes using simultaneous Hoechst 33342 labeling and immunophenotyping.Spatial characterization of glutathione depletion in the KHT sarcoma using flow cytometry.In vivo staining of mouse preimplantation embryos with Hoechst 33342.Addition of mitomycin C to cis-diamminedichloroplatinum(II)/hyperthermia/radiation therapy in the FSaIIC fibrosarcoma.Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells.Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo.Modification of tumour radiation response in vivo by the benzamide analogue pyrazinamide.Targeting breast tumors with pH (low) insertion peptidesImaging molecular dynamics in vivo--from cell biology to animal models.Effect of vascular marker Hoechst 33342 on tumour perfusion and cardiovascular function in the mouse.Lymphocytic infiltration and cytotoxicity under hypoxic conditions in the EMT6 mouse mammary tumor.Intermittent blood flow in the KHT sarcoma--flow cytometry studies using Hoechst 33342.Comparison of fluorescence intensity of Hoechst 33342-stained EMT6 tumour cells and tumour-infiltrating host cellsCharacterization of a carbocyanine derivative as a fluorescent penetration probe.Vascular volume in B16 allografts and human melanoma xenografts estimated by means of Hoechst 33342.Use of a carbocyanine dye as a marker of functional vasculature in murine tumoursRadiation sensitivity of tumour cells stained in vitro or in vivo with the bisbenzimide fluorochrome Hoechst 33342.Hoechst 33342 staining coupled with conventional histological technique.Characterization of radiation resistant hypoxic cell subpopulations in KHT sarcomas. (I). Centrifugal elutriation.Chemosensitization by misonidazole in CCNU-treated spheroids and tumoursResponse of spheroids implanted in the peritoneal cavity of mice exposed to cyclophosphamide and ionizing radiationCellular levels of photosensitisers in tumours: the role of proximity to the blood supplyInduction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy.The effects of carbogen and nicotinamide on intravascular oxyhaemoglobin saturations in SCCVII and KHT murine tumours.Hydroethidine: a fluorescent redox probe for locating hypoxic cells in spheroids and murine tumours.Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapyPatterns of mutagen binding and penetration in multicell spheroids.Characterization of radiation resistant hypoxic cell subpopulations in KHT sarcomas. (II). Cell sorting.Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumoursThe effects of melphalan and misonidazole on the vasculature of a murine sarcoma.Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.Chemical modification of tumour blood flow.Slow penetration of anthracyclines into spheroids and tumors: a therapeutic advantage?Factors that influence the penetration of methotrexate through solid tissue.Molecular imaging assisted surgery improves survival in a murine head and neck cancer model.
P2860
Q28364955-2A2052B0-8FA6-4D32-A4BC-90FD046CE34FQ32174436-C00EE1E9-D082-48A7-9F0B-3E4F793F4930Q33181737-ACB34FB0-8EC8-4BEA-BDF6-F9E79543276FQ33181864-93FEB9A2-8C03-44E8-A2C4-926E0A3E0FE1Q33190004-25025EA2-0BD0-4954-B4F4-4309C8225FD1Q33207809-CA81BF3C-8F96-4DD5-BAC2-AD4244CA4B70Q33246753-C3593076-E9CE-478A-B1AF-3326C3F603F5Q33256469-E231AD37-4FEA-4617-9456-6844BE372E63Q33309281-073B9BD3-A4A7-415B-89F5-40CA43737519Q33503545-75DB1353-7D35-42C9-AA2F-51012FF2F9EBQ33572476-39554047-4962-439A-B2B9-89A91707BC71Q33861033-D8056F81-104D-48D7-879B-C2FC31B0BAC2Q34011123-AEA484F8-9AE4-4044-9F04-B19D0A1B381FQ34211941-A3A97648-0DAE-48C7-BAF3-D2263CB0D1F1Q34263859-915CEBED-D955-470C-A39C-B0A771F84157Q34449663-88E82143-40DD-494C-9C9A-CFD06FC6CD9FQ34835981-0F44739F-CF8A-4664-B8FE-16E4B62DB1F4Q35086548-AD80FDBD-1787-4FB1-A665-104E7530593BQ35086566-A8FF4ADD-4036-45F0-9B82-06FDCBF4CDF1Q35131696-2BE26031-1F95-4C42-AC3E-C855D709D04CQ35144833-B4D47803-C492-4CB2-87D5-8CC314CFD209Q35159806-43056820-F757-4AB5-9DB1-EFAA21C5B8B1Q35168845-B62019A6-AC99-45E9-B976-46F67667DE09Q36027632-CCD2EB17-1EC5-4D5E-AA44-C1F7255ADC8CQ36028986-F2602705-D627-4B42-A52B-18C2AC871FCCQ36029068-B5AB247D-2D3A-4BEC-A666-B059446EF97BQ36079765-07D63A51-B191-491F-B391-ADEA973308E1Q36080465-517B6397-507F-4AA7-99E6-D33472A87F63Q36080887-82D56912-C7D2-4D14-AC97-A0ABDD53366AQ36207258-5DE124F5-0667-4C25-9B71-2602BA1837B5Q36378276-8A92E788-3AED-4D84-A991-923372D84ED3Q36430927-24AAAEE4-ACBF-429D-80F7-7B037120541BQ36437053-52B8E182-0451-418E-A25F-CE0C309E8C50Q36450490-EB4C562F-EFD6-43E5-891A-B2229B78FCA0Q36464321-31C5D6CF-2C5E-4270-ABEE-678D10A1A9EFQ37346912-64CFAEA1-BFFC-4608-979B-9FCAFFCA6562Q39648583-0342B257-3060-4BE5-AB16-68292695F059Q41749306-6A7338FD-818C-4764-858D-839F5C8A1F5EQ43517179-2FECF02A-5264-412B-8D53-1265C5045BF2Q50509011-8CF4FDFF-59A7-4EF3-AB6C-BC190B3AAD23
P2860
Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumours.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Pharmacokinetics, binding and ...... spheroids and murine tumours.
@ast
Pharmacokinetics, binding and ...... spheroids and murine tumours.
@en
type
label
Pharmacokinetics, binding and ...... spheroids and murine tumours.
@ast
Pharmacokinetics, binding and ...... spheroids and murine tumours.
@en
prefLabel
Pharmacokinetics, binding and ...... spheroids and murine tumours.
@ast
Pharmacokinetics, binding and ...... spheroids and murine tumours.
@en
P2093
P2860
P356
P1476
Pharmacokinetics, binding and ...... spheroids and murine tumours.
@en
P2093
D J Chaplin
R E Durand
P2860
P2888
P304
P356
10.1038/BJC.1985.252
P407
P577
1985-11-01T00:00:00Z